References
- Luketic VA, Sanyal AJ. Esophageal varices. I. Clinical presentation, medical therapy and endoscopic therapy. GI Clin North Am 2000; 29(2): 337–85
- Luketic VA, Sanyal AJ. Esophageal varices. II. Transjugular intrahepatic portosystemic shunt and surgical therapy. GI Clin North Am 2000; 29(2): 387–421
- Sanyal AJ, Purdum PP III, Luketic VA, et al. Bleeding gastroesophageal varices. Semin Liver Dis 1993; 13(4): 328–42
- The Veterans Affairs Cooperative Variceal Sclerotherapy Group. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease: a randomized, single-blind, multicenter clinical trial. N Engl J Med 1991; 324(25): 1779–84
- Sarin SK, Lamba GS, Kumar M, et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340(13): 988–93
- Sanyal AJ, Shiftman ML. Pharmacologic treatment of portal hypertension. In: Lewis JH, Dubois A, eds. Current clinical topics in gastrointestinal pharmacology. London: Blackwell Scientific, 1997: 242–75
- Angelico M, Carli L, Piat C, et al. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997; 113(5): 1632–9
- Merkel C, Marin R, Enzo E, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo Triveneto per L'Ipertensione portale. Lancet 1996; 348(9043): 1677–81
- Planas R, Quer JC, Boix J, et al. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994; 20(2): 370–5
- Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding: a meta-analysis. Ann Intern Med 1995; 123(4): 280–7
- Sanyal AJ, Freedman AM, Luketic VA, et al. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 1996; 111(1): 138–46